ADCENDO
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
ADCENDO
Social Links:
Industry:
Biotechnology Health Care
Founded:
2017-01-01
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.adcendo.dk
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
63.32 M USD
Technology used in webpage:
SPF Google Font API Microsoft Exchange Online Office 365 Mail LiteSpeed Lightspeed Cache Under Construction For WordPress Team.blue
Similar Organizations
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Advisors List
Sanne de Jongh Board Member @ ADCendo Board_member 2021-04-01
John Lambert Advisor @ ADCendo Advisor
Marten Steen Board Member @ ADCendo Board_member 2021-04-01
Vincent F.M.H. de Groot Advisor @ ADCendo Advisor
Joel Jean Mairet Board Member @ ADCendo Board_member 2021-04-01
Lars H. Engelholm Board Member @ ADCendo Board_member
Jeroen Bakker Board Member @ ADCendo Board_member 2021-04-01
Reza Halse Board Member @ ADCendo Board_member 2021-04-01
Current Employees Featured
Niels Behrendt
Niels Behrendt Co-founder @ ADCendo Co-founder
Dominik Mumberg
Dominik Mumberg Chief Scientific Officer @ ADCendo Chief Scientific Officer 2022-05-01
Henrik Stage
Henrik Stage CFO @ ADCendo CFO 2021-07-01
Henrik Stage
Henrik Stage Co-founder & CEO @ ADCendo Co-founder & CEO 2017-06-01
Lars H. Engelholm
Lars H. Engelholm Co-founder @ ADCendo Co-founder
Christoffer Nielsen
Christoffer Nielsen Co-founder & COO @ ADCendo Co-founder & COO
Founder
Christoffer Nielsen
Henrik Stage
Lars H. Engelholm
Niels Behrendt
Investors List
HealthCap
HealthCap investment in Series A - ADCendo
Gilde Healthcare
Gilde Healthcare investment in Series A - ADCendo
Ysios Capital
Ysios Capital investment in Series A - ADCendo
RA Capital Management
RA Capital Management investment in Series A - ADCendo
Novo Holdings
Novo Holdings investment in Series A - ADCendo
Novo Nordisk Foundation
Novo Nordisk Foundation investment in Grant - ADCendo
Key Employee Changes
Date | New article |
---|---|
2022-05-03 | Adcendo Appoints Dominik Mumberg, PhD, as Chief Scientific Officer |
Official Site Inspections
http://www.adcendo.dk
- Host name: linux25.curanet.dk
- IP address: 185.21.41.51
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
Loading ...